Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02725489
Title Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Mary Crowley Medical Research Center
Indications

ovarian cancer

cervical cancer

endometrial cancer

breast cancer

fallopian tube cancer

uterine cancer

peritoneum cancer

Therapies

Durvalumab + FANG vaccine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.